- Home
- TVRD vs SANG Comparison
TVRD vs SANG Comparison
Compare TVRD & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- SANG
- Stock Information
- Founded
- TVRD 2017
- SANG 1984
- Country
- TVRD United States
- SANG Canada
- Employees
- TVRD N/A
- SANG N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- TVRD Health Care
- SANG Technology
- Exchange
- TVRD Nasdaq
- SANG Nasdaq
- Market Cap
- TVRD 246.5M
- SANG 213.1M
- IPO Year
- TVRD N/A
- SANG 2021
- Fundamental
- Price
- TVRD $24.14
- SANG $5.81
- Analyst Decision
- TVRD Strong Buy
- SANG
- Analyst Count
- TVRD 5
- SANG 0
- Target Price
- TVRD $59.20
- SANG N/A
- AVG Volume (30 Days)
- TVRD 38.6K
- SANG 1.8K
- Earning Date
- TVRD 08-21-2025
- SANG 09-17-2025
- Dividend Yield
- TVRD N/A
- SANG N/A
- EPS Growth
- TVRD N/A
- SANG N/A
- EPS
- TVRD N/A
- SANG N/A
- Revenue
- TVRD N/A
- SANG $238,264,000.00
- Revenue This Year
- TVRD N/A
- SANG N/A
- Revenue Next Year
- TVRD N/A
- SANG $2.38
- P/E Ratio
- TVRD N/A
- SANG N/A
- Revenue Growth
- TVRD N/A
- SANG N/A
- 52 Week Low
- TVRD $8.13
- SANG $4.08
- 52 Week High
- TVRD $34.31
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- SANG 48.95
- Support Level
- TVRD N/A
- SANG $5.30
- Resistance Level
- TVRD N/A
- SANG $5.70
- Average True Range (ATR)
- TVRD 0.00
- SANG 0.08
- MACD
- TVRD 0.00
- SANG -0.03
- Stochastic Oscillator
- TVRD 0.00
- SANG 62.32
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.